Expansion Opportunities Recent product launches across multiple analyte lines (Linearity LQ Osmolality, Ammonia/Alcohol for Ortho Vitros, HbA1c, Urine Chemistry Panel, Abbott General Chemistry Panels, Roche and Stago compatibility) indicate ongoing portfolio growth and cross-sell potential to labs using these platforms. Focus sales efforts on labs upgrading instrument fleets or expanding assay menus, highlighting calibration verification and daily quality control solutions across these systems.

Laboratory Alignment AUDIT positions itself as a total solution provider for daily QC and calibration verification, with a strategic partnership (Aalto Scientific) that promises cost savings. Sales opportunities exist with labs seeking vendor consolidation, easier data management, and integrated QC workflows, especially in mid-sized labs that require reliable service and bundled pricing.

Digital Engagement Tech stack emphasis on user-friendly data management and digital tools suggests potential for selling enhanced data analytics, dashboards, and onboarding experiences. Target labs that prioritize ease-of-use and remote monitoring, offering demos of data management integrations and Cloudflare/Zoho-enabled security and accessibility.

Mid-Market Focus With 11-50 employees and revenues in the lower mid-market range, AUDIT is a fit for regional clinical laboratories and smaller hospital labs looking for scalable QC solutions. Sales plays can emphasize rapid deployment, personalized service, and cost-efficient calibration verification to win repeat business and expand into multiple departments.

Competitive Positioning Compared to much larger incumbents, AUDIT’s niche focus on total QC solutions, rapid product introductions, and strong service orientation can be leveraged to target labs seeking agility and customizable offerings. Highlight partnerships, broad assay compatibility, and proven track record of expanding calibration verification lines to drive trial opportunities and upsell.